The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology (한방안이비인후피부과학회지)

The Society of Korean Medicine Ophthalmology, Otolaryngology & Dermatology (대한한방안이비인후피부과학회)
권호 표지
DOI QR코드

DOI QR Code

Three Treatment Cases on Combined Korean Medicine of Adult Atopic Dermatitis with Chronic Stress

만성 스트레스를 동반한 성인형 아토피 피부염 환자의 한의 단독 치료 3례

  • Oh, Dong-Hwan (College of Korean Medicine, Woosuk University) ;
  • Kim, Ki-Baek (College of Korean Medicine, Woosuk University) ;
  • Jeong, Soung-Youn (College of Korean Medicine, Woosuk University) ;
  • Ha, Dong-Lim (Hadonglim Korean Medicine Clinic) ;
  • Lee, Seung-Ho (Dept. of Pathology, College of Korean Medicine, Woosuk University) ;
  • Jang, In-Soo (Dept. of Internal Medicine, College of Korean Medicine, Woosuk University) ;
  • Oh, Yong-Taek (Dept. of Diagnostics, College of Korean Medicine, Woosuk University) ;
  • Kim, Jun-Hyung (Sunchang Health Center and County Hospital, Sunchang, KR) ;
  • Choi, Yoo-Min (Dept. of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Woosuk University)
  • 오동환 (우석대학교 한의과대학 한의학과) ;
  • 김기백 (우석대학교 한의과대학 한의학과) ;
  • 정성연 (우석대학교 한의과대학 한의학과) ;
  • 하동림 (하동림 한의원) ;
  • 이승호 (우석대학교 한의과대학 병리학교실) ;
  • 장인수 (우석대학교 한의과대학 한방내과학교실) ;
  • 오용택 (우석대학교 한의과대학 진단학교실) ;
  • 김준형 (순창 보건의료원) ;
  • 최유민 (우석대학교 한의과대학 침구의학과)
  • Received : 2021.10.02
  • Accepted : 2021.11.10
  • Published : 2021.11.25
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The purpose of this study is to report 3 cases of Korean medical treatment on adult atopic dermatitis. Methods : Three patients with adult atopic dermatitits were treated with herbal medicine (Soyo-san hap Samul-tang), acupuncture, and moxibustion. Psychosomatic symptoms were considered the main criteria for treatment. The effects of treatment were evaluated through photographs of the lesions, using EASI and DLQI scores. Results : After treatment, EASI and DLQI scores on three atopic dermatitis patients improved significantly. Conclusions : This clinical case study has demonstrated that Korean medicine may be an effective option for treating adult atopic dermatitis. In addition, considering psychosomatic symptoms when treating atopic dermatitis may also lead to effective treatment.

Keywords

Acknowledgement

본 연구는 우석대학교의 교내 연구비 지원을 받아 수행되었음.

References

  1. Atopic Dermatitis Korean Medicine Clinical Practice Guideline. Korea Institute of Oriental Medince. 2015;26.
  2. Kwon JA, Roh KY, Koh BK, Kim JW.Original Article : Clinical characteristics of adolescence and adult atopic dermatitis inKorea. Korean Journal of Dermatology. 2004;42(8):949-54.
  3. Jang HS: Diagnosis and Treatment of Atopic Dermatitis. Korean Journal of Family Medicine. 2002;23(7):831-40.
  4. Park HJ, Kwon JH, Yoo JH. Quantity and Quality Assessment of Randomized Controlled Trials in the Atopic Dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2014; 27(4):45-57. https://doi.org/10.6114/JKOOD.2014.27.4.045
  5. Noh HM, Park SG, Heo ES, Jo EH, Park MC. The study about the comparision of Korean-Western Medicine on Atopic Dermatitis and Food Allergy. J Korean Med Ophthalmol Otolaryngol Dermatol. 2017;30(2):86-99. https://doi.org/10.6114/JKOOD.2017.30.2.086
  6. Oh HS, Kim BW. Anti-inflammatory activity of the water extract of Polygala tenuifolia Willd. Korean J Orient Int Med. 2013;34(2):204-14.
  7. Funakushi N, Yamaguchi T, Jiang J, Imamura S, Kuhara T, et al. Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice. Arch Dermatol Res. 2011;303(9):659-67. https://doi.org/10.1007/s00403-011-1137-9
  8. Kang DW, Kim YB. Aggravating and Mitigating Patient Factors Affecting Mild to Moderate Atopic Dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2020;33(4):1-15. https://doi.org/10.6114/JKOOD.2020.33.4.001
  9. Son BK, Choi IH. Research of Pattern identification and Outcome Measurement in Atopic Dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2008;21(3):150-65.
  10. Kim NK, Lee DH, Jo GW, Moon H, Seo ES. A study on the correlation between quality of life and disease severity in adult patients with atopic dermatitis. J Korean Med Ophthalmol Otolaryngol Dermatol. 2011;24(3):27-36. https://doi.org/10.6114/JKOOD.2011.24.3.027
  11. Kwon JA, Roh KY, Koh BK, Kim JW. Clinical Characteristics of Adolescence and Adult Atopic Dermatitis in Korea. Korean Journal of Dermatology. 2004;42(8):949-54.
  12. Ko ES, et al. The Clinical Review on three cases of UL-syndrome induced by Chronic Stress. Dept. of Oriental Internal Medicine Dongsuwon Oriental Hospital. The journal of internal Korean medicine. 2004;25(3):615-24.
  13. Je YM, Yoo DY. Two Case Report of UL-syndrome Treated with Gamisoyosan. Research Institute of Korean Medicine. 2011;19(2):187-94.
  14. Liu J, Zhang Y, Han M, Liu Z, Wang J, He Q. Chinese herbal formula Xiao Yao San for treatment of depression: A systematic review of randomized controlled trials. Evidence-based Complement Altern Med. 2011;2012:931636.
  15. Choi HM, K SJ, Kim IS, Lee JB, K JB, Moon SO, Lee HD. Evaluation on Anti-oxidant Activity and Anti-inflammatory Effects for the New Formulation of Gamisoyosan. The Korea journal of herbology. 2016;31(6):1-9. https://doi.org/10.6116/KJH.2016.31.6.1.
  16. Kobayashi, H., Takahashi, K., Mizuno, N., Kutsuna, H., & Ishii, M.. An Alternative Approach to Atopic Dermatitis: Part I-Case-Series Presentation. Evidence-based complementary and alternative medicine : eCAM, 2004;1(1):49-62. https://doi.org/10.1093/ecam/neh015
  17. Kim EK, Kim EY, Lee HS, Jung HS, Park SK, Sohn YJ, Sohn NW. Effect of Samul-Tang on the Allergic Inflammatory Response. Journal of physiology & pathology in Korean Medicine. 2007;21(3):617-25.
  18. Lee KS, Song BK, Cho BW. Effects of A Constituent Herbs of Samul-tang on Antithrombosis and Antistress. The Journal Of Oriental Gynecology. 1999;12(2):41-74.
  19. Cury M.J, Martins C, Aoki V, Gois AFT, Ishii HA, da Silva EMK. Topical tacrolimus for atopic dermatitis. Cochrane Database of Systematic Reviews. 2015;7.
  20. The Food and Drug Administration (FDA) Tacrolimus information. 2018[cited 2015 JULY 23]. Available from:URL: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/tacrolimus-marketed-protopic-ointment-information